Futura Medical Share Discussion Threads

[lbo] 24/4/2023 10:02

Its all so predictable because its all been done before! LOL

Hopefully who ever gives the convertible loan wont be dumping their cheap shares like Atlantis/Co-High did after the Chinese deal which seems to have come to nothing tangible in terms of Med3000 getting approval or being launched in China! Yet all the rampers pumped that deal too before Atlantis/Co-HIgh dumped!



2013

Chemist shops sold out of new treatment three times since product came out in June

flying off pharmacy shelves at the rate of 15,000 tubes a week

[lbo] 24/4/2023 09:56

Liberum says ˜other potential sources of income’

Like a convertible loan! Like Flexiseq did! LOL




The secured loan of US$15 million, which matures on June 25, 2018, will bear interest at 12% per annum plus other additional consideration. The interest rate will decrease to 10% if Pro Bono Bio meets certain equity-fundraising targets. The loan is secured by a charge over the assets of Pro Bono Bio and its affiliates which includes but is not limited to Flexiseqââ€&2;¢, an innovative topical pain product that has sales of more than 3 million units since its U.K. launch last year.



In 2017, PBB was on the verge of bankruptcy, because it could not pay interest on the loan of 15 million pounds, taken in 2015 by the Canadian Knight Therapeutics.

[petroc] 24/4/2023 09:37

A post of mine from last week:

'...and LiarBO knows all about the failure of CSD500! Before its launch he was singing FUM's praises, he'd clearly bought in big time. But then it failed, LiarBO was forced to sell at the bottom of the market because he'd invested more than he could afford to lose, and that started his 'Six Year War' against FUM. That's the length of time he's been bashing this stock. What an absolute fool and massive loser! If he hadn't made that schoolboy error of investing too much, he could be like the majority of LTHs here who made their money back. How do I know this? If you read back his posts, he was involved in quite a few threads, discussing his various holdings, but suddenly they all stopped at the same time CSD500 failed. He'd obviously switched his money to FUM and lost the lot. Haha!

And yet here he is, trying to dissuade any newbies or sniffers not to invest! You'd have to be really, really stupid to take any investment advice from that loser! You don't need to take my advice either because I'm not offering any, apart from the old adage 'if you see a bandwagon passing, you're already too late!' My prediction (and I've been right before) is that after a brief flurry this week, the share price will start to drift down again until the FDA rubber stamps the US approval to market. That'll be the big one! (Take note, Truant! That'll be when to put your imaginary short in!)'

So, just as I predicted last week, the share price is drifting downwards again. And who can blame LOM for taking a little profit? 1% of their holding as a 6 or 7 bagger, that's a lot of cash in their coffers.

[petroc] 24/4/2023 09:25

There's LiarBO misinforming again! Trying to pretend that FUM have taken out a secured loan, but he's talking about Flexiseq yet again. I know some people may think I'm overstating the case when I say that Flexiseq is a Russian gangster scam, it's actually true. The company was taken over by a Russian connected to the government, he signed over the distribution rights to his brother, and has taken state money and also secured loans against the company from various sources. It's clearly just a money making scam, and has absolutely nothing to do with FUM and Eroxon.

The fact that LiarBO keeps trying to connect FUM with Flexiseq just shows the level of deception and misinforming that he'll go to to bash this stock. He just makes himself look extremely dishonest with this kind of behaviour.

BTW, it's been a while since I researched the Flexiseq Russian scam, so there may be mistakes in what I said above, but those are the basic bones of the story, it's all there online.

[lbo] 24/4/2023 08:57

Anyone know what coincidentally can happen after Lombard sells shares like they are again according to todays RNS!

Ask J777J! LOL


J777J - 23 Dec 2019 - 08:45:36 - 7043 of 9296

Clearly feels like a stitch up by Lombard who shorted after the RNS knowing they would buy back in the placing? After all it was they that underwrote it. No TR1 announcement came from them. That after something near 35% to 40% of the company's shares changed hands!!! The mysterious Butler on their payroll????? This individual appeared out of the smoke as a duo act. The obvious tactic was to spread scare stories across the various bb's.Get the price as low as possible. Lombard appear as the white knight,the great saviours,but are they in fact ruthless market manipulators?

[waterloo01] 24/4/2023 08:35

Impressive sales via Boots. Be interesting if FUM announce any re-orders?

[lbo] 23/4/2023 22:15

As the fine print said in the Futura results ‘ royalties are not recognised in full until it is highly probable that a significant reversal in the amount of cumulative revenue recognised will not occur. In management’s opinion, that will be when the Group’s customer confirms that the milestone has been met or that a royalty is due’


As happened with Flexiseq! And with CSD500 and PE500! Seems to be all in under the control of Cooper! And lets not forget Cooper only agreed a 5 year deal and a year has gone already and the Med2005 patent which the brokers assume offers protection to Med3000 expires in the EU in 2025!

2013

Chemist shops sold out of new treatment three times since product came out in June

flying off pharmacy shelves at the rate of 15,000 tubes a week



In 2017, PBB was on the verge of bankruptcy, because it could not pay interest on the loan of 15 million pounds, taken in 2015 by the Canadian Knight Therapeutics.


And don’t forget the other fine print in other Futura agreements with other distributors regarding competitor products and patents not being granted or being enforceable



a agreed percentage of the net sales value (after transport costs, sales tax, credit notes for returns and defective products and any settlement, retrospective, volume and promotional discounts) charged by LRC or any sub-licensee in relation to the Product.

The royalty and the royalty advance may be reduced by such amount (if any) as is agreed or determined by an expert to be fair and reasonable if: (i) any patent application does not proceed to grant or any patent rights are determined to be unenforceable or are revoked or lapse; or (ii) an event occurs which in LRC reasonable opinion adversely affects the commercial viability of the licence agreement or the margins on sales of the Product; or (iii) a competing product is offered

[haroldthegreat] 23/4/2023 20:16

if Boots are selling at 25 they have probably got the price down to £10 or less . it probably costs less than £2 to make . Someone in the industry now can probably give a better guestimate ! Boots have over 2200 branches in Uk .

[suresure] 23/4/2023 19:04

What Royalty pc are FUM expected to net, 20%?

[broomrigg] 23/4/2023 17:35

Page refreshed at 1734.....

Last sale 25 seconds ago!

You gotta love it :-)

[broomrigg] 23/4/2023 17:32

Page refreshed at 1732.....

Last sale 2 seconds ago!

Say no more Rodders :-)

[broomrigg] 23/4/2023 17:30

Time for a sales check at 1728hrs.....

Last sale of Eroxon via boots.com......23 seconds ago

Luverly jubberly Rodders :-)

[lbo] 23/4/2023 16:29

Also note the reference to ‘highly probable that a significant reversal in the amount of cumulative revenue recognised will not occur’

Oh dear!

Just like Pet500 and CSD500 could have been something more then a one hit wonder for a short time but failed to sell long term even though they had more USPs and enforceable patents! Yet Reckitt still have similar products to those Futura failed products on the market! And they and GSK both walked away from MED! I wonder why?

If It does get De Novo medical device registration and there actually is a real market for drug free male arousal gels for psychogenic ED. It wont take long for Reckitt or competitors if they are inclined to launch a similar alcohol, water, glycol and Carbopol arousal gel product for men via the 510k pathway!

A De Novo premarket review pathway, a regulatory pathway for low- to moderate-risk devices of a new type. Along with this De Novo authorization, the FDA is establishing criteria called special controls that define the requirements related to labeling and performance testing. When met, the special controls, in combination with general controls, provide a reasonable assurance of safety and effectiveness for devices of this type. This action also creates a new regulatory classification, which means that subsequent devices of the same type with the same intended use may go through the FDA 510(k) pathway, whereby devices can obtain clearance by demonstrating substantial equivalence to a predicate device

The average length of time for clearance under the traditional 510(k) pathway is 177 days,



A company must compare their product to one already cleared by the FDA and provide evidence that their product is substantially equivalent to the previously cleared (legally marketed) device. To be substantially equivalent, the product must meet criteria for the same intended use, have the same technology or (slightly) different technology but produces similar end results, and be safe and effective. Once pre-market clearance is received from the FDA the device can be distributed commercially



Here's a startling fact: between 80% and 90% of new product launches fail, according to multiple studies including Harvard Business Review. Each year, more than 30,000 new products hit the market, from companies large and small, and year after year, history is littered with dead carcasses



Research at the Ehrenberg-Bass Institute shows new product launches can be a risky undertaking for brand owners. Investigating 83,719 new product introductions over an eight-year period, the research finds around one in four new products failed to survive one year after launch. This failure rate increased to around 40% two years after launch.



Why Most Product Launches Fail

[lbo] 23/4/2023 16:25

As always with Futura the key is in the wording! Interesting they aren’t technically delivering ‘pharmaceutical product’ with Eroxon? Its a Medical device product?

But note the wording about ‘net invoice’ ‘less estimated volume discounts’ which are ‘variable’ but ‘significant’



During the year, the Company entered into contracts for supply of goods to external customers against orders received. The majority of contracts that the Company enters into relate to sales orders containing single performance obligation for the delivery of pharmaceutical products. Revenue is recognised when control of the goods is passed to the customer. The point at which control passes is determined by each customer arrangement, but generally occurs when title passes to the customer, either on shipment or on receipt of goods by the customer, depending on local trading terms.

Product revenue represents net invoice less estimated volume discounts, which are considered to be variable consideration and include significant estimates. Other variable considerations such as milestone payments and royalties are not recognised in full until it is highly probable that a significant reversal in the amount of cumulative revenue recognised will not occur. In management’s opinion, that will be when the Group’s customer confirms that the milestone has been met or that a royalty is due. Estimates associated with variable consideration are revisited at each reporting date or when they are resolved and revenue is adjusted accordingly

[lbo] 23/4/2023 16:08

Yet no queue! LOL







2013

Chemist shops sold out of new treatment three times since product came out in June

flying off pharmacy shelves at the rate of 15,000 tubes a week



In 2017, PBB was on the verge of bankruptcy, because it could not pay interest on the loan of 15 million pounds, taken in 2015 by the Canadian Knight Therapeutics.

[dontshoutatonce] 23/4/2023 15:19

Wrong. 10 seconds ago.

[broomrigg] 23/4/2023 12:44

Last sale of Eroxon via boots.com......29 seconds ago.Nice ;-)